Skip to main content
Caplight Logo









Niraxx Light Therapeutics

Niraxx Light Therapeutics

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://niraxx.com/

Last Round

Series A

Jul 1, 2024

Total Funding Raised

$68,968

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Niraxx Light Therapeutics is a neurotech company that develops wearable healthcare products and digital platforms utilizing photobiomodulation (PBM) technology to treat mental health conditions and improve brain health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

photobiomodulationPBMneurotechnologywearable neurostimulationbrain healthe-textilenear-infrared light therapybiohackingmental health techdigital health platformnon-invasive therapyhealth IoTwearable wellnessneuromodulationsmart headband

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Niraxx Light Therapeutics Comparables

Compare Niraxx Light Therapeutics with similar companies based on industry and business-model similarity.

Niraxx Light Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sens.ai Incorporated
87%
Vielight Inc.
84%
Neuronic
83%

Niraxx Light Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2024
CrowdfundingApr 1, 2019

Key People

Founding team and executive leadership

Ronald Stoute

Chief Technology Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 226% MoM.

  • Feb 2, 2026

    Monthly visitors grew 45% MoM, reaching 1.1K.

Niraxx Light Therapeutics Filings

Explore SEC and related filing metadata, where available.

Niraxx Light Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Niraxx Light Therapeutics's valuation, stock price, and market status.

Is Niraxx Light Therapeutics a public or private company?

Niraxx Light Therapeutics is a private company.

What is the current stock price of Niraxx Light Therapeutics?

Niraxx Light Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Niraxx Light Therapeutics worth (valuation)?

Valuation information for Niraxx Light Therapeutics is not publicly available.

Can I buy Niraxx Light Therapeutics stock?

Niraxx Light Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Niraxx Light Therapeutics's last funding round?

Niraxx Light Therapeutics's most recent funding round was Series A on July 1, 2024.

Who are the main investors in Niraxx Light Therapeutics?

Investor information for Niraxx Light Therapeutics is not publicly disclosed.

Will Niraxx Light Therapeutics IPO soon?

No public IPO plans have been announced for Niraxx Light Therapeutics.

How can I track Niraxx Light Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Niraxx Light Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range7
Year Founded2016
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?